Analysts Expect Wright Medical Group NV (WMGI) to Announce $0.03 Earnings Per Share

Equities analysts forecast that Wright Medical Group NV (NASDAQ:WMGI) will post earnings per share of $0.03 for the current fiscal quarter, according to Zacks Investment Research. Sixteen analysts have provided estimates for Wright Medical Group’s earnings, with the highest EPS estimate coming in at $0.05 and the lowest estimate coming in at $0.01. Wright Medical Group posted earnings of ($0.01) per share in the same quarter last year, which indicates a positive year over year growth rate of 400%. The firm is scheduled to issue its next quarterly earnings results on Wednesday, May 8th.

According to Zacks, analysts expect that Wright Medical Group will report full-year earnings of $0.21 per share for the current fiscal year, with EPS estimates ranging from $0.12 to $0.26. For the next year, analysts forecast that the business will report earnings of $0.50 per share, with EPS estimates ranging from $0.34 to $0.64. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Wright Medical Group.

Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings results on Tuesday, February 26th. The medical device company reported $0.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.05. Wright Medical Group had a positive return on equity of 0.02% and a negative net margin of 20.27%. The business had revenue of $238.15 million during the quarter, compared to analysts’ expectations of $237.86 million. During the same period in the previous year, the business posted $0.10 earnings per share. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year.

WMGI has been the subject of a number of research analyst reports. BidaskClub raised Wright Medical Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 13th. Needham & Company LLC reiterated a “buy” rating and issued a $35.00 price objective on shares of Wright Medical Group in a research report on Monday, January 7th. UBS Group initiated coverage on Wright Medical Group in a research report on Wednesday, November 28th. They issued a “neutral” rating and a $31.00 price objective for the company. BMO Capital Markets lifted their price objective on Wright Medical Group from $33.00 to $36.00 and gave the stock an “outperform” rating in a research report on Thursday, March 14th. Finally, Cantor Fitzgerald lifted their price objective on Wright Medical Group from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 27th. Two investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $34.62.

Shares of Wright Medical Group stock traded down $0.02 during trading on Tuesday, reaching $31.66. The company’s stock had a trading volume of 827,266 shares, compared to its average volume of 1,581,377. The company has a quick ratio of 0.90, a current ratio of 1.29 and a debt-to-equity ratio of 0.98. Wright Medical Group has a one year low of $19.01 and a one year high of $32.86.

In other news, Director John L. Miclot sold 10,309 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $32.05, for a total transaction of $330,403.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kevin C. Oboyle sold 3,583 shares of the business’s stock in a transaction dated Friday, February 15th. The stock was sold at an average price of $32.01, for a total value of $114,691.83. The disclosure for this sale can be found here. Over the last quarter, insiders sold 64,582 shares of company stock valued at $1,997,258. Corporate insiders own 4.00% of the company’s stock.

Several institutional investors have recently bought and sold shares of WMGI. Advisors Asset Management Inc. acquired a new position in shares of Wright Medical Group during the 4th quarter worth about $30,000. Exane Derivatives acquired a new position in shares of Wright Medical Group during the 4th quarter worth about $42,000. FTB Advisors Inc. grew its position in shares of Wright Medical Group by 94.9% during the 4th quarter. FTB Advisors Inc. now owns 1,604 shares of the medical device company’s stock worth $43,000 after buying an additional 781 shares during the period. First Quadrant L P CA acquired a new position in shares of Wright Medical Group during the 4th quarter worth about $72,000. Finally, IFP Advisors Inc acquired a new position in shares of Wright Medical Group during the 4th quarter worth about $75,000.

Wright Medical Group Company Profile

Wright Medical Group NV operates as a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes.

Further Reading: No Load Funds

Get a free copy of the Zacks research report on Wright Medical Group (WMGI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.